[Fibrinolytic therapy--plasminogen activator inhibitors].
D001018:Aortic Diseases / Q000628:therapy*; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D007511:Ischemia / Q000097:blood / Q000628:therapy*; D007866:Leg / Q000098:blood supply*; D010960:Plasminogen Activators / Q000037:antagonists & inhibitors*; D015849:Plasminogen Inactivators; D011994:Recombinant Proteins / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use*; D013924:Thrombophlebitis / Q000097:blood / Q000628:therapy*; D013927:Thrombosis / Q000628:therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D006023:Glycoproteins; D015849:Plasminogen Inactivators; D011994:Recombinant Proteins; D013300:Streptokinase; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator
Fibrinolytische Therapie--Plasminogenaktivatorinhibitoren.